MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q1
hinzugefügt 12.05.2026
Land |
 Kanada |
IPO-Jahr |
2014 |
Branche |
Arzneimittelhersteller |
Börse |
NASDAQ GLOBAL |
Anteile |
21.3 M |
Marktkapitalisierung |
$ 193 M |
EBITDA (LTM) |
$ -106 M |
P/E (LTM) |
- |
P/S (LTM) |
3.78 |
EPS (LTM) |
-4.51 |
Andere Aktien der Branche "Arzneimittelhersteller"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
- | - | $ 28.9 M | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Evoke Pharma
EVOK
|
- | - | $ 36.6 M | Nasdaq Capital Market |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 5.72 | -2.39 % | $ 85 M | Nasdaq Global Select Market | USA |
 |
HEXO Corp.
HEXO
|
- | 2.45 % | $ 38.1 M | NYSE | Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
- | -0.1 % | $ 2.03 B | Nasdaq Global Select Market |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
- | 7.5 % | $ 6.35 M | Nasdaq Global Market | USA |
 |
DURECT Corporation
DRRX
|
- | - | $ 50.1 M | Nasdaq Capital Market | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
- | 0.86 % | $ 117 M | Nasdaq Capital Market | USA |
 |
Aerie Pharmaceuticals
AERI
|
- | - | $ 754 M | Nasdaq Global Market,SPB | USA |
 |
Agile Therapeutics
AGRX
|
- | 10.11 % | $ 58.2 M | Nasdaq Capital Market | USA |
 |
Alimera Sciences
ALIM
|
- | - | $ 142 M | Nasdaq Global Market | USA |
 |
Cronos Group
CRON
|
$ 2.79 | 0.72 % | $ 1.07 B | Nasdaq Global Market | Canada |
 |
Athenex
ATNX
|
- | -23.39 % | $ 1.76 M | Nasdaq Global Select Market | USA |
 |
Harrow Health
HROW
|
$ 33.46 | 1.09 % | $ 1.23 B | Nasdaq Global Market | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
- | - | $ 2.06 B | Nasdaq Global Select Market |  France |
 |
Catalent
CTLT
|
- | - | $ 11.5 B | NYSE,SPB | USA |
 |
Organogenesis Holdings
ORGO
|
$ 2.48 | 4.2 % | $ 314 M | Nasdaq Capital Market | USA |
 |
Eagle Pharmaceuticals
EGRX
|
- | -39.89 % | $ 27.7 M | Nasdaq Global Market,SPB | USA |
 |
Canopy Growth Corporation
CGC
|
$ 1.02 | - | $ 110 M | Nasdaq Global Select Market | Canada |
 |
Pacira BioSciences
PCRX
|
$ 23.21 | 1.53 % | $ 1.07 B | Nasdaq Global Select Market,SPB | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 1.11 | 1.83 % | $ 1.38 M | Nasdaq Capital Market | USA |
 |
Solid Biosciences
SLDB
|
$ 6.57 | 2.5 % | $ 575 M | Nasdaq Global Select Market,SPB | USA |
 |
Aurora Cannabis
ACB
|
$ 3.38 | -0.88 % | $ 185 M | NYSE | Canada |
 |
Jupiter Wellness
JUPW
|
- | - | $ 33.6 M | Nasdaq Global Select Market | USA |
 |
Lannett Company
LCI
|
- | 1.15 % | $ 7.11 M | NYSE | USA |
 |
OrganiGram Holdings
OGI
|
$ 1.08 | 0.93 % | $ 103 M | Nasdaq Global Select Market | Canada |
 |
Tilray
TLRY
|
$ 5.17 | 2.78 % | $ 3.19 B | Nasdaq Global Select Market | Canada |
 |
Evolus
EOLS
|
$ 6.7 | 0.3 % | $ 432 M | Nasdaq Global Market | USA |
 |
Sundial Growers
SNDL
|
$ 1.46 | 0.69 % | $ 3.37 M | Nasdaq Global Select Market | Canada |
 |
Emergent BioSolutions
EBS
|
$ 7.95 | -0.63 % | $ 425 M | NYSE,SPB | USA |
 |
Veru
VERU
|
$ 3.1 | 3.33 % | $ 45.4 M | Nasdaq Capital Market | USA |
 |
cbdMD
YCBD
|
$ 0.72 | -0.69 % | $ 2.9 M | NYSE American | USA |
 |
Assertio Holdings
ASRT
|
$ 23.46 | 0.13 % | $ 150 M | Nasdaq Capital Market | USA |
 |
ProPhase Labs
PRPH
|
- | - | $ 5.07 M | Nasdaq Capital Market | USA |
 |
Radius Health
RDUS
|
- | - | $ 1.42 B | Nasdaq Global Market | USA |
 |
Bausch Health Companies
BHC
|
$ 5.17 | 1.17 % | $ 1.92 B | NYSE | Canada |
 |
PetIQ
PETQ
|
- | 1.64 % | $ 400 M | Nasdaq Global Select Market,SPB | USA |
 |
Relmada Therapeutics
RLMD
|
$ 6.27 | 9.62 % | $ 248 M | Nasdaq Global Select Market,SPB | USA |
 |
Recro Pharma
REPH
|
- | -4.76 % | $ 65.3 M | Nasdaq Global Select Market | USA |
 |
OptiNose
OPTN
|
- | - | $ 1.08 B | Nasdaq Global Select Market | USA |
 |
SCYNEXIS
SCYX
|
$ 4.36 | -2.02 % | $ 218 M | Nasdaq Global Select Market | USA |
 |
PLx Pharma
PLXP
|
- | -27.8 % | $ 2.56 M | Nasdaq Capital Market | USA |
 |
Viatris
VTRS
|
$ 16.2 | 1.69 % | $ 18.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Zomedica Corp.
ZOM
|
- | -0.21 % | $ 98 M | NYSE American | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
- | - | $ 55.5 M | Nasdaq Global Market,SPB | USA |
 |
Rockwell Medical
RMTI
|
$ 0.69 | 3.81 % | $ 24.8 M | Nasdaq Global Market | USA |
 |
Tricida
TCDA
|
- | - | $ 3.25 M | Nasdaq Global Select Market,SPB | USA |
 |
China Pharma Holdings
CPHI
|
$ 0.72 | 0.75 % | $ 3.09 M | NYSE American |  China |
 |
TherapeuticsMD
TXMD
|
$ 1.88 | - | $ 21.7 M | Nasdaq Global Select Market | USA |